Cost and cost-effectiveness guidelines: which ones to use?

被引:46
作者
Walker, D [1 ]
机构
[1] London Sch Hyg & Trop Med, Hlth Policy Unit, Hlth Econ & Financing Programme, London WC1E 7HT, England
关键词
D O I
10.1093/heapol/16.1.113
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Given the increased awareness of the importance of cost-effectiveness in health care, there has been a growth in the number of published economic evaluations in recent years. Partly in response to concerns about deficiencies in the methodology of published studies, there has been a growth of interest in guidelines for economic evaluation. This paper reviews the various objectives of economic analyses, and then summarizes the existing groups of guidelines for cost and cost-effectiveness analyses. Finally, it compares and discusses the appropriate uses and limitations of the guidelines, with particular emphasis on those developed for applications in developing countries.
引用
收藏
页码:113 / 121
页数:9
相关论文
共 45 条
  • [1] Disability-adjusted life years: a critical review
    Anand, S
    Hanson, K
    [J]. JOURNAL OF HEALTH ECONOMICS, 1997, 16 (06) : 685 - 702
  • [2] [Anonymous], 2000, Costing guidelines for HIV prevention strategies
  • [3] [Anonymous], PRINCIPLES COST BENE
  • [4] [Anonymous], GUID PROJ EV
  • [5] Baladi JF, 1998, HEALTH ECON, V7, P221, DOI 10.1002/(SICI)1099-1050(199805)7:3<221::AID-HEC341>3.0.CO
  • [6] 2-N
  • [7] Opening the debate on DALYs
    Barker, C
    Green, A
    [J]. HEALTH POLICY AND PLANNING, 1996, 11 (02) : 179 - 183
  • [8] *CCOHTA, 1994, GUID EC EV PHARM CAN
  • [9] *CDHHCS, 1992, GUID PHARM IND PREP
  • [10] Creese A, 1994, Cost Analysis in Primary Health Care. A Training Manual for Programme Managers